cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Intan Juniarmi
Contact Email
nawalaedu@gmail.com
Phone
+6281374694015
Journal Mail Official
nawalaedu@gmail.com
Editorial Address
Jl. Raya Yamin No.88 Desa/Kelurahan Telanaipura, kec.Telanaipura, Kota Jambi, Jambi Kode Pos : 36122
Location
Kota jambi,
Jambi
INDONESIA
Journal of Pharmacopoeia
Published by PT Anagata Sembagi Education
ISSN : -     EISSN : 30474469     DOI : https://doi.org/10.62872/ft811p22
Core Subject : Health,
Medicine & Pharmacology
The journal publishes original articles on current issues and trends occurring internationally in Clinical Pharmacy, Pharmaceutical Chemistry, Pharmaceutics, Community Pharmacy, Pharmacognosy, Phytochemistry.
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Ilmu Farmasi
Articles 5 Documents
 1 
Search results for , issue "Vol. 2 No. 2 (2025): SEPTEMBER-JP" : 5 Documents clear
Building a Bridge Between Research and Practice: Transforming the Pharmaceutical Industry in the digital Era Loso Judijanto; Jacky Chin; Apt. Irfan Ahsani
Journal of Pharmacopoeia Vol. 2 No. 2 (2025): SEPTEMBER-JP
Publisher : Pt. Anagata Sembagi Education

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62872/d2n5fq22

Abstract

This study aims to describe the role of digital transformation in bridging research and practice in the pharmaceutical industry, while identifying emerging barriers and opportunities. The method used is qualitative research with a descriptive approach, through in-depth interviews, observations, and documentation studies of pharmaceutical industry stakeholders. The results show that digitalization through the use of artificial intelligence, big data analytics, blockchain, and telepharmacy can accelerate the translation of research findings into industrial practice. However, this transformation still faces obstacles such as limited human resources, high investment costs, and regulations that are not yet fully adaptive. This study emphasizes that collaboration between academia, industry, and regulators, supported by digital technology, is key to building a more efficient, innovative, and evidence-based pharmaceutical industry model in the digital era
Community Pharmacy: The Role of Strategy in Increasing Access and Quality of Health Services Nikmah Nuur Rochmah; Norma Winata
Journal of Pharmacopoeia Vol. 2 No. 2 (2025): SEPTEMBER-JP
Publisher : Pt. Anagata Sembagi Education

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62872/x5p2qb66

Abstract

This study aims to analyze the strategic role of community pharmacies in improving access to and quality of healthcare services. The research method used was qualitative with a descriptive approach. Data were collected through in-depth interviews with pharmacists, patients, and stakeholders, observations of pharmacy services, and documentation studies related to operational standards and policies. Data analysis was conducted using the Miles & Huberman model through data reduction, data presentation, and conclusion drawing. The results showed that the strategies implemented by community pharmacies include expanding operating hours, digitizing services, providing medication delivery services, improving pharmacist competency, and implementing pharmaceutical service standards. These strategies have had a positive impact on improving public access to pharmaceutical services and the quality of healthcare services. However, challenges remain, including limited human resources, technological constraints in certain regions, and suboptimal regulations. This study confirms that community pharmacies have a strategic role in supporting the primary healthcare system and need to be supported by more comprehensive policies.
The Role of Clinical Pharmacy in Preventing Complications of Metabolic Syndrome Annis Rahmawaty
Journal of Pharmacopoeia Vol. 2 No. 2 (2025): SEPTEMBER-JP
Publisher : Pt. Anagata Sembagi Education

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62872/mvketm08

Abstract

Metabolic syndrome is a cluster of interacting metabolic risk factors, including central obesity, hypertension, insulin resistance, hyperglycemia, and atherogenic dyslipidemia, which significantly increase the risk of cardiovascular disease and type 2 diabetes mellitus. The prevalence of metabolic syndrome continues to increase globally due to changes in sedentary lifestyles and high-calorie consumption patterns, making it a public health issue with serious clinical, social, and economic impacts. The resulting complications, such as coronary heart disease, stroke, chronic kidney failure, and neuropathy, not only worsen patients' quality of life but also increase long-term healthcare costs. Therefore, preventing complications needs to be prioritized with strategies that integrate healthy lifestyle modifications, medical interventions, and rational pharmacotherapy. Clinical pharmacists play a strategic role in the management of metabolic syndrome through medication therapy management (MTM), patient education, drug interaction detection, and increased therapy adherence. Interdisciplinary collaboration between pharmacists, physicians, nurses, nutritionists, and psychologists strengthens the effectiveness of comprehensive, more personalized interventions. This study uses qualitative methods through a literature review to analyze the role of clinical pharmacists in preventing metabolic syndrome complications. The results show that integrating the role of clinical pharmacists into the healthcare team, supported by regulations, technology, and ongoing training, is key to reducing the risk of complications and improving people's quality of life. 
Analysis of Bioactive Content in Indonesian Local Superfoods as a Preventative of Degenerative Diseases Elen Christ Tambunan
Journal of Pharmacopoeia Vol. 2 No. 2 (2025): SEPTEMBER-JP
Publisher : Pt. Anagata Sembagi Education

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62872/jtsw1p76

Abstract

Degenerative diseases such as diabetes, cancer, and heart disease pose a major challenge to modern public health. One potential preventative measure is the use of local Indonesian superfoods rich in bioactive compounds. This study aims to identify the main bioactive compounds in various local Indonesian superfoods and explore their potential in preventing degenerative diseases. The research method used was a qualitative one with a literature study approach obtained from scientific journals, research reports, and interviews with nutritionists and food experts. Data analysis was conducted through content analysis with categorization of bioactives and their relationship to disease prevention mechanisms. The results showed that local superfoods such as moringa, tempeh, purple sweet potato, turmeric, ginger, mangosteen, guava, and soursop contain important bioactives such as flavonoids, polyphenols, isoflavones, anthocyanins, curcumin, gingerol, and acetogenins. These compounds act as antioxidants, anti-inflammatories, immunomodulators, and protective agents for cells, thus having significant potential in preventing degenerative diseases. These findings confirm that local Indonesian superfoods have strategic value not only as functional foods, but also as part of preventive public health efforts and national food sovereignty.
Study of Public Knowledge on the Use of Herbal Medicines and Their Interactions Loso Judijanto
Journal of Pharmacopoeia Vol. 2 No. 2 (2025): SEPTEMBER-JP
Publisher : Pt. Anagata Sembagi Education

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62872/fyfrt185

Abstract

The use of herbal medicines has increased significantly in the past two decades, particularly in developing countries like Indonesia. This phenomenon is largely influenced by the perception that herbal medicines are safer due to their natural nature, although public understanding of scientific aspects, such as dosage, drug interactions, and side effects, remains very limited. Various studies have shown that combinations of herbal and conventional medicines, such as ginkgo biloba with anticoagulants or St. John's wort with antidepressants, can cause dangerous pharmacological interactions, including toxicity and decreased therapeutic efficacy. The lack of formal health education and the dominance of information from social media and advertising exacerbate misinformation in the community. Furthermore, many health workers have not received training in herbal pharmacology, thus preventing them from providing optimal evidence-based education. Weak regulations on the distribution and labeling of herbal products also contribute to the risk of unsafe self-medication practices. This study used a literature review with a qualitative-descriptive approach to assess the level of public knowledge and the risks of herbal drug interactions. The results are expected to form the basis for the development of integrative educational and regulatory policies to improve public health literacy and ensure safer, more rational, and evidence-based use of herbal medicines.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2025 2025


Reset
Filter By Issues
All Issue Vol. 2 No. 2 (2025): SEPTEMBER-JP Vol. 2 No. 1 (2025): MARCH-JP Vol. 1 No. 2 (2024): SEPTEMBER-JP Vol. 1 No. 1 (2024): MARET-JP